http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7001893-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16
filingDate 2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae1c749b481e9b1680a39573ee55acfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5395e82b8b7679313cda570a46c55585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf3b3c4a8e4b521cc7209df16a00307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85545dd7a198196f85388340456bf3c7
publicationDate 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7001893-B2
titleOfInvention Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
abstract The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for synthesizing inclusion complexes of the anti-tubercular drug, Rifampicin, with β-CD (β-cyclodextrin) and HP-β-CD (2-hydroxy propyl cyclodextrin) and characterization of these inclusion complexes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4098282-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3892303-A1
priorityDate 2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5134127-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6495160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6500463-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135925261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136136478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136122621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136145328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128193010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135825534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129066678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135736016

Total number of triples: 49.